Rchr
J-GLOBAL ID:200901017816733012   Update date: Jun. 09, 2020

Tomoda Keishiro

トモダ ケイシロウ | Tomoda Keishiro
Research field  (1): Pharmaceuticals - analytical and physicochemistry
Research keywords  (1): Pharmaceutical physicochemistry
Research theme for competitive and other funds  (1):
  • 2005 - 2015 Development of inhalable nanoformulation for treatment of lung cancer.
MISC (31):
Lectures and oral presentations  (21):
  • 肺がん細胞選択性向上を目指したナノ粒子製剤開発
    (第27回日本DDS学会学術集会 2011)
  • PLGA Nanospheres for Transdermal Carrier
    (Third Indo-Japanese International Joint Symposium on Overcoming Intractable Infectious Diseases Prevalent in Asian Countries 2010)
  • Crystallinity of Trehalose Dihydrate Particles Estimated Using Terahertz Spectroscopy
    (Third Indo-Japanese International Joint Symposium on Overcoming Intractable Infectious Diseases Prevalent in Asian Countries 2010)
  • Inhalable Nanocomposite Particles for Cure for Tuberculosis
    (Third Indo-Japanese International Joint Symposium on Overcoming Intractable Infectious Diseases Prevalent in Asian Countries 2010)
  • Treatment of Lung Carcinoma Using Inhalable Nanocomposite Particles
    (Third Indo-Japanese International Joint Symposium on Overcoming Intractable Infectious Diseases Prevalent in Asian Countries 2010)
more...
Education (2):
  • - 2008 Tokyo University of Science Graduate school, division of pharmaceutical research
  • - 2003 Tokyo University of Science Faculty of pharmaceutical sciences
Professional career (1):
  • Ph.D(pharmaceutical sciences) (Tokyo University of Science)
Work history (4):
  • 2005 - 2008 Tokyo University of Science Research assistant
  • 2008 - Tokyo University of Science Assistant professor
  • Tokyo Institute of Technology Research Institute of Science and Technology Specially Appointed Assistant Professor
  • Tokyo University of Science Assistant Professor
Awards (1):
  • 2010 - Excellent Poster Award
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page